Skip to content
Senna
Senna is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Top OTC Drugs
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
senna-sOTC monograph not final2023-06-19
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A06: Drugs for constipation
A06A: Drugs for constipation
A06AB: Contact laxatives
A06AB06: Senna glycosides
A06AB56: Senna glycosides, combinations
HCPCS
No data
Clinical
Clinical Trials
85 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248HP_0002019K59.0146919
Type 2 diabetes mellitusD003924EFO_0001360E11224
HyperlipidemiasD006949EFO_0003774E78.5112
Colorectal neoplasmsD015179112
HypercholesterolemiaD006937HP_0003124112
DyslipidemiasD050171HP_000311911
FlushingD005483R23.211
NeoplasmsD009369C8011
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fecal incontinenceD005242R152135
DyspareuniaD004414HP_0030016N94.1112
AtrophyD00128411
MenopauseD008593EFO_0003922N9511
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
DyspneaD004417HP_0002094R06.011
Rectal neoplasmsD01200411
Colonic neoplasmsD003110C1811
ColonoscopyD003113111
AnemiaD000740EFO_0004272D64.911
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Male breast neoplasmsD018567112
Inflammatory bowel diseasesD015212EFO_0003767112
Healthy volunteers/patients112
ObesityD009765EFO_0001073E66.911
Breast neoplasmsD001943EFO_0003869C5011
Metabolic syndromeD024821EFO_0000195E88.8111
Ulcerative colitisD003093EFO_0000729K5111
GastroparesisD018589EFO_1000948K31.8411
Gastrointestinal diseasesD00576711
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary tract infectionsD014552EFO_0003103N39.011
Urogenital abnormalitiesD01456411
DysuriaD053159EFO_0003901R3011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Irritable bowel syndromeD043183EFO_0000555K5844
Chronic kidney failureD007676EFO_0003884N18.633
Renal dialysisD006435EFO_0010690Z99.222
Healthy dietD00007200122
Necrotizing enterocolitisD020345EFO_0003928K55.311
Hirschsprung diseaseD006627Q43.111
ColostomyD00312511
Meconium ileusD000074270P76.011
EncopresisD004688F98.111
Autistic disorderD001321EFO_0003758F84.011
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSENNA
INN
Description
Senna (senna) is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID128-57-4
RxCUI
ChEMBL IDCHEMBL2108558
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 6,868 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
268,444 adverse events reported
View more details